# XORTX Therapeutics Inc.: Form 6-K, filed Aug 4, 2026

- Company: [XORTX Therapeutics Inc.](/companies/xrtx.md) (CIK 1729214)
- Form: 6-K
- Filed: 2026-08-04
- Accepted by EDGAR: Aug 4, 2026, 00:35 ET
- Period: 2026-07-31
- Accession: 0001171843-26-005158
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1729214/000117184326005158/f6k_080426.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1729214/000117184326005158/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1729214/000117184326005158/f6k_080426.htm

Filed Aug 4, 2026.
Source: SEC EDGAR, the filing index for accession 0001171843-26-005158. Last ingested by Listed: Oct 24, 2026, 15:07 ET. No prices; not investment advice.